ALX-1393 is a glycine reuptake inhibitor.

[2] This causes elevated levels of glycine, an inhibitory neurotransmitter.

This is thought to be due to the elevated glycine levels reducing the transmission of the pain signals.

[3] Tests have shown that it was able to help reduce cancer pain in a potent way.

This pharmacology-related article is a stub.